Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

Antibodies to proteins/peptides containing citrulline are hallmarks of Rheumatoid Arthritis (RA). These antibodies are strongly associated with the expression of the Shared Epitope (SE). RA patients also generate antibodies to homocitrulline-containing proteins/peptides (also referred to as anti-car...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of autoimmunity 2018-05, Vol.89, p.75-81
Hauptverfasser: Lac, Patrick, Saunders, Sheri, Tutunea-Fatan, Elena, Barra, Lillian, Bell, David A., Cairns, Ewa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 81
container_issue
container_start_page 75
container_title Journal of autoimmunity
container_volume 89
creator Lac, Patrick
Saunders, Sheri
Tutunea-Fatan, Elena
Barra, Lillian
Bell, David A.
Cairns, Ewa
description Antibodies to proteins/peptides containing citrulline are hallmarks of Rheumatoid Arthritis (RA). These antibodies are strongly associated with the expression of the Shared Epitope (SE). RA patients also generate antibodies to homocitrulline-containing proteins/peptides (also referred to as anti-carbamylated protein antibodies (Anti-CarP)). This study was undertaken to investigate the relationship between homocitrulline and citrulline immune responses using an established mouse model of RA: DR4-transgenic (DR4tg) mice that express the human SE. C57BL/6 (B6) and DR4tg (on a B6 background) mice were immunized subcutaneously with a homocitrullinated peptide (HomoCitJED). Splenic T cell proliferation was evaluated by 3H-thymidine incorporation assay. Antibodies to homocitrullinated and citrullinated antigens were screened by enzyme-linked immunosorbent assay (ELISA). Antibody cross-reactivity was examined by inhibition with HomoCitJED and its citrullinated counterpart peptide, CitJED (the number of homocitrullines in HomoCitJED is equal to the number of citrullines in CitJED). HomoCitJED-immunized DR4tg mice developed early T and B cell responses to HomoCitJED and late responses to CitJED. These mice also developed anti-CCP2 antibodies. In some mice, antibodies to HomoCitJED were also reactive to CitJED. B6 mice immunized with HomoCitJED developed late T and B cell responses to HomoCitJED, but did not generate responses to citrullinated antigens. Unlike DR4tg mice, anti-HomoCitJED antibodies from B6 mice did not react to CitJED. In conclusion, DR4tg mice immunized with HomoCitJED developed immune responses to CitJED, indicating cross-reactivity. CitJED immune responses were dependent on the SE. HomoCitJED responses occurred in the absence of the SE (B6 mice); however, they developed earlier in DR4tg SE-expressing mice. •Homocitrullinated peptide-immunized DR4tg mice that express the Shared Epitope develop immune responses to homocitrulline.•Anti-homocitrulline, but not anti-citrulline immune responses can occur in the absence of the Shared Epitope.•Antibodies from homocitrullinated peptide-immunized DR4tg mice are cross-reactive to homocitrulline and citrulline.
doi_str_mv 10.1016/j.jaut.2017.12.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1977780114</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0896841117305814</els_id><sourcerecordid>1977780114</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-f7b6486f24a4ee3c451ce7dd99fec11e9a0b5cbf1cb7a78ed3326eeaba3b835e3</originalsourceid><addsrcrecordid>eNp9kE1rFTEUhoNY7G31D7iQLN3MmJOZTGbAjbRqC4VC0XXIJGd6c5lJxiQjuOlvN5dbxZWbfMDzvpzzEPIWWA0Mug-H-qC3XHMGsgZeM8ZfkB2wQVQDCPmS7Fg_dFXfApyTi5QOjAEIIV6Rcz7wljPW78jT7bJsHmnEtAafMNEc6Iprdra8TfBZO-_8I92HJRiX4zbPrvAh0n9-ztO8R3r90FY5ap8e0TtDl7AlLKfFmYaJxj1ui87BWapj3keXXXpNziY9J3zzfF-S718-f7u6qe7uv95efbqrTCO6XE1y7Nq-m3irW8TGtAIMSmuHYUIDgINmozDjBGaUWvZom4Z3iHrUzdg3AptL8v7Uu8bwY8OU1eKSwXnWHsuUCgYpZV_8tAXlJ9TEkFLESa3RLTr-UsDU0bs6qKN3dfSugKvivYTePfdv44L2b-SP6AJ8PAFYtvzpMKpkHHqD1kU0Wdng_tf_G97wmG8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1977780114</pqid></control><display><type>article</type><title>Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis</title><source>Elsevier ScienceDirect Journals</source><creator>Lac, Patrick ; Saunders, Sheri ; Tutunea-Fatan, Elena ; Barra, Lillian ; Bell, David A. ; Cairns, Ewa</creator><creatorcontrib>Lac, Patrick ; Saunders, Sheri ; Tutunea-Fatan, Elena ; Barra, Lillian ; Bell, David A. ; Cairns, Ewa</creatorcontrib><description>Antibodies to proteins/peptides containing citrulline are hallmarks of Rheumatoid Arthritis (RA). These antibodies are strongly associated with the expression of the Shared Epitope (SE). RA patients also generate antibodies to homocitrulline-containing proteins/peptides (also referred to as anti-carbamylated protein antibodies (Anti-CarP)). This study was undertaken to investigate the relationship between homocitrulline and citrulline immune responses using an established mouse model of RA: DR4-transgenic (DR4tg) mice that express the human SE. C57BL/6 (B6) and DR4tg (on a B6 background) mice were immunized subcutaneously with a homocitrullinated peptide (HomoCitJED). Splenic T cell proliferation was evaluated by 3H-thymidine incorporation assay. Antibodies to homocitrullinated and citrullinated antigens were screened by enzyme-linked immunosorbent assay (ELISA). Antibody cross-reactivity was examined by inhibition with HomoCitJED and its citrullinated counterpart peptide, CitJED (the number of homocitrullines in HomoCitJED is equal to the number of citrullines in CitJED). HomoCitJED-immunized DR4tg mice developed early T and B cell responses to HomoCitJED and late responses to CitJED. These mice also developed anti-CCP2 antibodies. In some mice, antibodies to HomoCitJED were also reactive to CitJED. B6 mice immunized with HomoCitJED developed late T and B cell responses to HomoCitJED, but did not generate responses to citrullinated antigens. Unlike DR4tg mice, anti-HomoCitJED antibodies from B6 mice did not react to CitJED. In conclusion, DR4tg mice immunized with HomoCitJED developed immune responses to CitJED, indicating cross-reactivity. CitJED immune responses were dependent on the SE. HomoCitJED responses occurred in the absence of the SE (B6 mice); however, they developed earlier in DR4tg SE-expressing mice. •Homocitrullinated peptide-immunized DR4tg mice that express the Shared Epitope develop immune responses to homocitrulline.•Anti-homocitrulline, but not anti-citrulline immune responses can occur in the absence of the Shared Epitope.•Antibodies from homocitrullinated peptide-immunized DR4tg mice are cross-reactive to homocitrulline and citrulline.</description><identifier>ISSN: 0896-8411</identifier><identifier>EISSN: 1095-9157</identifier><identifier>DOI: 10.1016/j.jaut.2017.12.002</identifier><identifier>PMID: 29242008</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Anti-citrullinated protein/peptide antibodies ; Anti-homocitrullinated (carbamylated) protein/peptide antibodies ; Cross-reactivity ; Mouse model ; Rheumatoid arthritis ; Shared Epitope</subject><ispartof>Journal of autoimmunity, 2018-05, Vol.89, p.75-81</ispartof><rights>2017 Elsevier Ltd</rights><rights>Copyright © 2017 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-f7b6486f24a4ee3c451ce7dd99fec11e9a0b5cbf1cb7a78ed3326eeaba3b835e3</citedby><cites>FETCH-LOGICAL-c356t-f7b6486f24a4ee3c451ce7dd99fec11e9a0b5cbf1cb7a78ed3326eeaba3b835e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaut.2017.12.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29242008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lac, Patrick</creatorcontrib><creatorcontrib>Saunders, Sheri</creatorcontrib><creatorcontrib>Tutunea-Fatan, Elena</creatorcontrib><creatorcontrib>Barra, Lillian</creatorcontrib><creatorcontrib>Bell, David A.</creatorcontrib><creatorcontrib>Cairns, Ewa</creatorcontrib><title>Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis</title><title>Journal of autoimmunity</title><addtitle>J Autoimmun</addtitle><description>Antibodies to proteins/peptides containing citrulline are hallmarks of Rheumatoid Arthritis (RA). These antibodies are strongly associated with the expression of the Shared Epitope (SE). RA patients also generate antibodies to homocitrulline-containing proteins/peptides (also referred to as anti-carbamylated protein antibodies (Anti-CarP)). This study was undertaken to investigate the relationship between homocitrulline and citrulline immune responses using an established mouse model of RA: DR4-transgenic (DR4tg) mice that express the human SE. C57BL/6 (B6) and DR4tg (on a B6 background) mice were immunized subcutaneously with a homocitrullinated peptide (HomoCitJED). Splenic T cell proliferation was evaluated by 3H-thymidine incorporation assay. Antibodies to homocitrullinated and citrullinated antigens were screened by enzyme-linked immunosorbent assay (ELISA). Antibody cross-reactivity was examined by inhibition with HomoCitJED and its citrullinated counterpart peptide, CitJED (the number of homocitrullines in HomoCitJED is equal to the number of citrullines in CitJED). HomoCitJED-immunized DR4tg mice developed early T and B cell responses to HomoCitJED and late responses to CitJED. These mice also developed anti-CCP2 antibodies. In some mice, antibodies to HomoCitJED were also reactive to CitJED. B6 mice immunized with HomoCitJED developed late T and B cell responses to HomoCitJED, but did not generate responses to citrullinated antigens. Unlike DR4tg mice, anti-HomoCitJED antibodies from B6 mice did not react to CitJED. In conclusion, DR4tg mice immunized with HomoCitJED developed immune responses to CitJED, indicating cross-reactivity. CitJED immune responses were dependent on the SE. HomoCitJED responses occurred in the absence of the SE (B6 mice); however, they developed earlier in DR4tg SE-expressing mice. •Homocitrullinated peptide-immunized DR4tg mice that express the Shared Epitope develop immune responses to homocitrulline.•Anti-homocitrulline, but not anti-citrulline immune responses can occur in the absence of the Shared Epitope.•Antibodies from homocitrullinated peptide-immunized DR4tg mice are cross-reactive to homocitrulline and citrulline.</description><subject>Anti-citrullinated protein/peptide antibodies</subject><subject>Anti-homocitrullinated (carbamylated) protein/peptide antibodies</subject><subject>Cross-reactivity</subject><subject>Mouse model</subject><subject>Rheumatoid arthritis</subject><subject>Shared Epitope</subject><issn>0896-8411</issn><issn>1095-9157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kE1rFTEUhoNY7G31D7iQLN3MmJOZTGbAjbRqC4VC0XXIJGd6c5lJxiQjuOlvN5dbxZWbfMDzvpzzEPIWWA0Mug-H-qC3XHMGsgZeM8ZfkB2wQVQDCPmS7Fg_dFXfApyTi5QOjAEIIV6Rcz7wljPW78jT7bJsHmnEtAafMNEc6Iprdra8TfBZO-_8I92HJRiX4zbPrvAh0n9-ztO8R3r90FY5ap8e0TtDl7AlLKfFmYaJxj1ui87BWapj3keXXXpNziY9J3zzfF-S718-f7u6qe7uv95efbqrTCO6XE1y7Nq-m3irW8TGtAIMSmuHYUIDgINmozDjBGaUWvZom4Z3iHrUzdg3AptL8v7Uu8bwY8OU1eKSwXnWHsuUCgYpZV_8tAXlJ9TEkFLESa3RLTr-UsDU0bs6qKN3dfSugKvivYTePfdv44L2b-SP6AJ8PAFYtvzpMKpkHHqD1kU0Wdng_tf_G97wmG8</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Lac, Patrick</creator><creator>Saunders, Sheri</creator><creator>Tutunea-Fatan, Elena</creator><creator>Barra, Lillian</creator><creator>Bell, David A.</creator><creator>Cairns, Ewa</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201805</creationdate><title>Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis</title><author>Lac, Patrick ; Saunders, Sheri ; Tutunea-Fatan, Elena ; Barra, Lillian ; Bell, David A. ; Cairns, Ewa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-f7b6486f24a4ee3c451ce7dd99fec11e9a0b5cbf1cb7a78ed3326eeaba3b835e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Anti-citrullinated protein/peptide antibodies</topic><topic>Anti-homocitrullinated (carbamylated) protein/peptide antibodies</topic><topic>Cross-reactivity</topic><topic>Mouse model</topic><topic>Rheumatoid arthritis</topic><topic>Shared Epitope</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lac, Patrick</creatorcontrib><creatorcontrib>Saunders, Sheri</creatorcontrib><creatorcontrib>Tutunea-Fatan, Elena</creatorcontrib><creatorcontrib>Barra, Lillian</creatorcontrib><creatorcontrib>Bell, David A.</creatorcontrib><creatorcontrib>Cairns, Ewa</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of autoimmunity</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lac, Patrick</au><au>Saunders, Sheri</au><au>Tutunea-Fatan, Elena</au><au>Barra, Lillian</au><au>Bell, David A.</au><au>Cairns, Ewa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis</atitle><jtitle>Journal of autoimmunity</jtitle><addtitle>J Autoimmun</addtitle><date>2018-05</date><risdate>2018</risdate><volume>89</volume><spage>75</spage><epage>81</epage><pages>75-81</pages><issn>0896-8411</issn><eissn>1095-9157</eissn><abstract>Antibodies to proteins/peptides containing citrulline are hallmarks of Rheumatoid Arthritis (RA). These antibodies are strongly associated with the expression of the Shared Epitope (SE). RA patients also generate antibodies to homocitrulline-containing proteins/peptides (also referred to as anti-carbamylated protein antibodies (Anti-CarP)). This study was undertaken to investigate the relationship between homocitrulline and citrulline immune responses using an established mouse model of RA: DR4-transgenic (DR4tg) mice that express the human SE. C57BL/6 (B6) and DR4tg (on a B6 background) mice were immunized subcutaneously with a homocitrullinated peptide (HomoCitJED). Splenic T cell proliferation was evaluated by 3H-thymidine incorporation assay. Antibodies to homocitrullinated and citrullinated antigens were screened by enzyme-linked immunosorbent assay (ELISA). Antibody cross-reactivity was examined by inhibition with HomoCitJED and its citrullinated counterpart peptide, CitJED (the number of homocitrullines in HomoCitJED is equal to the number of citrullines in CitJED). HomoCitJED-immunized DR4tg mice developed early T and B cell responses to HomoCitJED and late responses to CitJED. These mice also developed anti-CCP2 antibodies. In some mice, antibodies to HomoCitJED were also reactive to CitJED. B6 mice immunized with HomoCitJED developed late T and B cell responses to HomoCitJED, but did not generate responses to citrullinated antigens. Unlike DR4tg mice, anti-HomoCitJED antibodies from B6 mice did not react to CitJED. In conclusion, DR4tg mice immunized with HomoCitJED developed immune responses to CitJED, indicating cross-reactivity. CitJED immune responses were dependent on the SE. HomoCitJED responses occurred in the absence of the SE (B6 mice); however, they developed earlier in DR4tg SE-expressing mice. •Homocitrullinated peptide-immunized DR4tg mice that express the Shared Epitope develop immune responses to homocitrulline.•Anti-homocitrulline, but not anti-citrulline immune responses can occur in the absence of the Shared Epitope.•Antibodies from homocitrullinated peptide-immunized DR4tg mice are cross-reactive to homocitrulline and citrulline.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29242008</pmid><doi>10.1016/j.jaut.2017.12.002</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0896-8411
ispartof Journal of autoimmunity, 2018-05, Vol.89, p.75-81
issn 0896-8411
1095-9157
language eng
recordid cdi_proquest_miscellaneous_1977780114
source Elsevier ScienceDirect Journals
subjects Anti-citrullinated protein/peptide antibodies
Anti-homocitrullinated (carbamylated) protein/peptide antibodies
Cross-reactivity
Mouse model
Rheumatoid arthritis
Shared Epitope
title Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T09%3A13%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20responses%20to%20peptides%20containing%20homocitrulline%20or%20citrulline%20in%20the%20DR4-transgenic%20mouse%20model%20of%20rheumatoid%20arthritis&rft.jtitle=Journal%20of%20autoimmunity&rft.au=Lac,%20Patrick&rft.date=2018-05&rft.volume=89&rft.spage=75&rft.epage=81&rft.pages=75-81&rft.issn=0896-8411&rft.eissn=1095-9157&rft_id=info:doi/10.1016/j.jaut.2017.12.002&rft_dat=%3Cproquest_cross%3E1977780114%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1977780114&rft_id=info:pmid/29242008&rft_els_id=S0896841117305814&rfr_iscdi=true